文献速递颈动脉与弓上血管

颈动脉干预后微栓塞的相关危险因素

Risk factors associated with microembolization after carotid intervention.
PubMed 文献 · J Vasc Surg · 2019-09-05

这项前瞻性队列研究纳入202例颈动脉狭窄患者,比较颈动脉支架置入术(CAS)与颈动脉内膜剥脱术(CEA)后微栓塞发生率及相关因素。结果显示CAS组微栓塞发生率显著高于CEA组(78% vs 27%,P < .0001)。在CAS患者中,颈外动脉通畅、病变钙化和病变长度是围手术期栓塞的独立危险因素,这些因素在CEA患者中未增加风险。

要点

  • CAS术后微栓塞发生率显著高于CEA(78% vs 27%)。
  • CAS患者中颈外动脉通畅、病变钙化和病变长度与微栓塞独立相关。
  • 识别术前危险因素有助于筛选患者并减少栓塞相关神经认知损害。

核心结论

  • CAS患者围手术期微栓塞风险高于CEA患者。
  • CAS患者微栓塞风险与病变长度和钙化相关。

研究设计与样本

  • 前瞻性队列研究,纳入202例颈动脉狭窄患者,其中CAS 107例,CEA 95例。
  • 所有患者术前和术后24小时内接受3T脑磁共振扩散加权成像以识别新发栓塞病变。

主要发现

  • CAS组微栓塞发生率为78%,CEA组为27%,差异有统计学意义(P < .0001)。
  • CAS患者中,颈外动脉通畅(OR 11.4;95%CI 1.11-117.6;P = .04)、病变钙化(OR 5.68;95%CI 1.12-28.79;P = .04)和病变长度(OR 0.29;95%CI 0.08-1.01;P = .05)是围手术期栓塞的独立危险因素。
  • 上述因素在CEA患者中未显示增加风险。

关键数值与推荐

  • CAS患者微栓塞发生率78%,CEA患者27%(P < .0001)。
  • CAS患者颈外动脉通畅OR 11.4(95%CI 1.11-117.6;P = .04)。
  • CAS患者病变钙化OR 5.68(95%CI 1.12-28.79;P = .04)。
  • CAS患者病变长度OR 0.29(95%CI 0.08-1.01;P = .05)。

临床怎么用

  • 术前评估CAS患者时应关注颈外动脉通畅性、病变钙化和病变长度,以识别微栓塞高风险患者。
  • 对于高风险患者,可考虑个体化选择血运重建方式以降低栓塞相关神经认知损害风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microembolization after carotid artery stenting (CAS) and carotid endarterectomy (CEA) has been documented and may confer risk for neurocognitive impairment. Patients undergoing stenting are known to be at higher risk for microembolization. In this prospective cohort study, we compare the microembolization rates for patients undergoing CAS and CEA and perioperative characteristics that may be associated with microembolization. METHODS: Patients undergoing CAS and CEA were prospectively recruited under local institutional review board approval from an academic medical center. All patients also received 3T brain magnetic resonance imaging with a diffusion-weighted imaging sequence preoperatively and within 24 hours postoperatively to identify procedure-related new embolic lesions. Preoperative, postoperative, procedural factors, and plaque characteristics were collected. Factors were tested for statistical significance with logistic regression. RESULTS: A total of 202 patients were enrolled in the study. There were 107 patients who underwent CAS and 95 underwent CEA. Patients undergoing CAS were more likely to have microemboli than patients undergoing CEA (78% vs 27%; P < .0001). For patients undergoing CAS, patency of the external carotid artery (odds ratio [OR], 11.4; 95% confidence interval [CI], 1.11-117.6; P = .04), lesion calcification (OR, 5.68; 95% CI, 1.12-28.79; P = .04), and lesion length (OR, 0.29; 95% CI, 0.08-1.01; P = .05) were all found to be independent risk factors for perioperative embolization. These factors did not confer increased risk to patients undergoing CEA. CONCLUSIONS: Patients undergoing CAS are at higher risk for perioperative embolization. The risk for perioperative embolization is related to the length of the lesion and calcification. Identifying the preoperative risk factors may help to guide patient selection and, thereby, reduce embolization-related neurocognitive impairment.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sabat J, Bock D, Hsu CH, et al. Risk factors associated with microembolization after carotid intervention. J Vasc Surg. 2019. PMID: 31493967. doi:10.1016/j.jvs.2019.06.202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。